Cite

    Yanagisawa, K. et al. (2020). Albuminuria‐lowering effect of sodium‐glucose cotransporter 2 inhibitors could be partly attributable to the attenuation of tubular damage in type 2 diabetic patients. Diabetes/metabolism research and reviews. 36 (7), p. n/a. [Online].